Response to Misused and Misleading: 100% Response Rate to Galcanezumab in Patients With Episodic Migraine

Authors

N. Rosen, Zucker School of Medicine at Hofstra/Northwell
E. Pearlman
D. Ruff
K. Day
A. J. Nagy

Publication Date

2019

Journal Title

Headache

Volume Number

59

Issue Number

4

Pages

627 - 628

Document Type

Article

Status

Faculty

Facility

School of Medicine

Primary Department

Neurology

PMID

30973202

DOI

10.1111/head.13514